While Orthofix's trauma business is growing slower than the market, it has an enormous opportunity in the U.S.

U.S. Market Key to Unlocking Orthofix’s Trauma Business

While Orthofix’s trauma business is growing slower than the market, it has an enormous opportunity in the U.S.

The Numbers
Stay up to date on the orthopedic market's 4Q performance in 2023 as we update this post with company sales data and industry developments.

Orthopedic Volume Trends Remained Strong in Fourth Quarter

Stay up to date on the orthopedic market’s 4Q performance in 2023 as we update this post with company sales data and industry developments.

Funding announcements came from familiar names and supported well-backed markets like spine and enabling technology.

10 Orthopedic Companies Close New Funding Rounds in 1Q24

Funding announcements came from familiar names and supported well-backed markets like spine and enabling technology.

Orthoflash®
NovApproach Spine OneLIF Cage
First Use of OneLIF Cage with Laterally-Positioned Patient

The device from NovApproach Spine supports the spectrum of anterior approaches with multi-insertion/multi-fixation technology.

,
Stryker Gamma4 Hip Fracture Nail
Stryker Gamma4 Hip Fracture Nail Launches in Europe

Gamma4 is indicated for the treatment of fractures in the intracapsular, trochanteric, subtrochanteric and shaft regions of the femur.

,
GID BIO completed enrollment for the first of two pivotal Phase III studies to investigate the use of your own stromal vascular fraction cells to treat osteoarthritis of the knee.
GID BIO Completes Enrollment for Cell Therapy Study

GID BIO completed enrollment for the first of two pivotal Phase III studies to investigate the use of your own stromal vascular fraction cells to treat osteoarthritis of the knee.

,
PainTEQ LinQ SI Joint Stabilization System
Final Study Data: Posterior Approach to SI Joint Fusion with PainTEQ’s LinQ

SI joint fusion with PainTEQ’s LinQ SI Joint Stabilization System shows promise for treating patients with sacroiliac joint dysfunction.

,
The patent addresses RemeOs' magnesium-calcium-zinc alloy composition and includes its use in the manufacturing of orthopedic implants.
Bioretec’s RemeOs Composition Allowed U.S. Patent

The patent addresses RemeOs’ magnesium-calcium-zinc alloy composition and includes its use in the manufacturing of orthopedic implants.

,
Competitive Landscape
Industry Voices

Contact Us

0